Aarti Drugs Limited: management transactions · India · SEBI (PIT + SAST) SEBI:aarti-drugs-limited IN IN · SEBI (PIT + SAST) Mcap 31.0Bn€
Browse the full management transaction log of Aarti Drugs Limited, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €31bn. The latest transaction was disclosed on 1 April 2022 — Purchase. Among the most active insiders: Safechem Enterprises Private Limited. All data is openly available.
Financial data FY ended March 2025 · cache
Income statement
Revenue 23.69 Bn€
Gross profit 8.45 Bn€ 36% margin
Net income 1.68 Bn€ 7.1% margin
Balance sheet & cash
Market cap 31.01 Bn€
Total debt 6.15 Bn€
Free Cash Flow 674.2 M€
Last declaration on 1 April 2022
Declarations 67 total
Executives ● Purchase0 SEBI
€277,976 53,500 shares @ €5.1958
Equity Shares
SEBI:7ebe6f289a05c28eb6e8501faf6fa394e23439f6 · 31 Mar 2022
Ideal exit: 26 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€130,955 25,000 shares @ €5.2382
Equity Shares
SEBI:747147572648e5e25866cf3fc68dd6efdb9fa581 · 31 Mar 2022
Ideal exit: 26 Dec 2022 (T+270) Executives ● Sale0 SEBI
€856,509 164,500 shares @ €5.2067
Equity Shares
SEBI:3a9fe497324dac3c2285044272b150405bdf912a · 31 Mar 2022
Executives ● Purchase0 SEBI
€73,335 14,000 shares @ €5.2382
Equity Shares
SEBI:705cb443842637d2a2db1fe008dae568c5d04138 · 31 Mar 2022
Ideal exit: 26 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€57,621 11,000 shares @ €5.2382
Equity Shares
SEBI:4c7b82e7d5ad6bb2bba5c445d591797c0c9b31d6 · 31 Mar 2022
Ideal exit: 26 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€261,884 50,000 shares @ €5.2377
Equity Shares
SEBI:772990de212fbe437710799e3934274cb217caf4 · 31 Mar 2022
Ideal exit: 26 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€631,359 120,000 shares @ €5.2613
Equity Shares
SEBI:4cb306523b3cff167265c8eaccd8fb3d6fd2bf08 · 28 Mar 2022
Ideal exit: 23 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€366,963 70,000 shares @ €5.2423
Equity Shares
SEBI:4dd9d6ec3cd7435e359970ce740b30cd8c75106c · 28 Mar 2022
Ideal exit: 23 Dec 2022 (T+270) Executives ● Sale0 SEBI
€947,569 180,615 shares @ €5.2463
Equity Shares
SEBI:9e317954615d4f72aad39c2c6b33b859a0370625 · 28 Mar 2022
Executives ● Purchase0 SEBI
€3,313 609 shares @ €5.4397
Equity Shares
SEBI:291c302e44702c60108378a3b14559eb6e4281b3 · 2 Mar 2022
Ideal exit: 27 Nov 2022 (T+270) Executives ● Purchase0 SEBI
€3,046 500 shares @ €6.0913
Equity Shares
SEBI:628de7709512da35f476ccd9d68b904cdfbb417b · 20 Dec 2021
Ideal exit: 16 Sept 2022 (T+270) Executives ● Purchase0 SEBI
€124 20 shares @ €6.2128
Equity Shares
SEBI:3206cff2e73608a9d0375a3fed090c3190f2a56c · 24 Nov 2021
Ideal exit: 21 Aug 2022 (T+270) Executives ● Purchase0 SEBI
€2,698 500 shares @ €5.3956
Equity Shares
SEBI:eed19423223a3c4a224e31e9f0dab6e1b1a38dc8 · 28 Feb 2022
Ideal exit: 25 Nov 2022 (T+270) Executives ● Purchase0 SEBI
€3,040 500 shares @ €6.0799
Equity Shares
SEBI:a1d92dbd4a5f7f0bd032964a1312b71fbddf2ef0 · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) Executives ● Purchase0 SEBI
€50,512 8,600 shares @ €5.8735
Equity Shares
SEBI:b00f8633b13ba29b8481f45487a317d3cfbf87e8 · 15 Feb 2022
Ideal exit: 12 Nov 2022 (T+270) Executives ● Sale0 SEBI
€61,808 10,000 shares @ €6.1808
Equity Shares
SEBI:3e15f0aadcb9df236aa025e38d215cf3f70ecc06 · 30 Dec 2021
Executives ● Sale0 SEBI
€441,620 71,258 shares @ €6.1975
Equity Shares
SEBI:ff9bd60328c1d7a36c7c8315373282d9ca146315 · 29 Dec 2021
Executives ● Sale0 SEBI
€81,280 13,120 shares @ €6.1951
Equity Shares
SEBI:d15ece23fe7275bb06d4145c4ad33b62f4bde008 · 27 Dec 2021
Executives ● Sale0 SEBI
€53,122 8,705 shares @ €6.1025
Equity Shares
SEBI:be1f323b539b4719e2257bdf50cb32b5ca21cc5e · 23 Dec 2021
Executives ● Sale0 SEBI
€276,745 45,000 shares @ €6.1499
Equity Shares
SEBI:f86e303f1bce743f0148e37e7c58c9aecb569798 · 24 Dec 2021
Executives ● Sale0 SEBI
€11,720 1,917 shares @ €6.1139
Equity Shares
SEBI:70713a810f0014cfb0ba8d519edd770551804385 · 22 Dec 2021
Executives ● Purchase0 SEBI
€1,211 200 shares @ €6.0551
Equity Shares
SEBI:3c10af7cc70cfd376b05420835f7e57129416b71 · 21 Dec 2021
Ideal exit: 17 Sept 2022 (T+270) Executives ● Purchase0 SEBI
€64,641 10,741 shares @ €6.0181
Equity Shares
SEBI:280e403ce2e39363ac5a4224f3f94a251f92548c · 1 Dec 2021
Ideal exit: 28 Aug 2022 (T+270) Executives ● Purchase0 SEBI
€117,580 19,200 shares @ €6.1239
Equity Shares
SEBI:d97b94d555595295656c643f997bec9d945c325f · 30 Nov 2021
Ideal exit: 27 Aug 2022 (T+270) Executives ● Sale0 SEBI
€138,354 19,647 shares @ €7.042
Equity Shares
SEBI:25e8608ef38e5ffab2db757188b904240293fbc5 · 30 Sept 2021
25 of 67 declarations
Load more (42 remaining) About Aarti Drugs Limited Aarti Drugs Limited is an Indian company engaged in the manufacturing of pharmaceutical products. It is listed on the Bombay Stock Exchange.